Telix Pharmaceuticals Limited revenue for the last year amounted to 468.06 M EUR, the most of which — 460.83 M EUR — came from its highest performing source at the moment, Precision Medicine. The greatest contribution to the revenue figure was made by United States — last year it brought Telix Pharmaceuticals Limited 455.57 M EUR, and the year before that — 302.02 M EUR.